SCHEMBL3433348

SCHEMBL3433348

C#Cc1ccc(Br)cc1F

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PYCR1 P32322 1/20 0.42
DGAT1 O75907 1/20 0.39
KDM1A O60341 2/20 0.37
KDM1B Q8NB78 1/20 0.37
CYP11B1 P15538 1/20 0.35
CYP11B2 P19099 1/20 0.35
ACACB O00763 1/20 0.35
TRPV4 Q9HBA0 1/20 0.33
NPC1 O15118 3/20 0.32
LMNA P02545 3/20 0.32
RAB9A P51151 3/20 0.32
SMN1; SMN2 Q16637 3/20 0.32
ALDH1A1 P00352 2/20 0.32
TP53 P04637 1/20 0.32
HPGD P15428 1/20 0.32
ALOX12 P18054 1/20 0.32
GAA P10253 1/20 0.31
KMT2A Q03164 1/20 0.31
CYP2A6 P11509 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29658059 1.00 PYCR1 (0.42) PYCR1DGAT1KDM1AKDM1BCYP11B1
SCHEMBL5958536 0.82 PYCR1 (0.39) PYCR1DGAT1KDM1AKDM1BNPC1
SCHEMBL27214759 0.81 ACACB (0.46) PYCR1DGAT1KDM1AKDM1BCYP11B1
SCHEMBL56634 0.77 TRPV4 (0.57) CYP11B1CYP11B2TRPV4
SCHEMBL2366749 0.77 DGAT1 (0.44) PYCR1DGAT1KDM1AKDM1BCYP11B1
SCHEMBL14661873 0.77 DGAT1 (0.39) PYCR1DGAT1KDM1AKDM1BCYP11B1
SCHEMBL29661807 0.76 HSP90AA1 (0.46) PYCR1LMNASMN1; SMN2ALDH1A1HPGD
SCHEMBL30111761 0.76 ALDH1A1 (0.42) CYP11B1CYP11B2TRPV4ALDH1A1CYP2A6
SCHEMBL434666 0.76 ALDH1A1 (0.42) CYP11B1CYP11B2TRPV4ALDH1A1CYP2A6
SCHEMBL4746042 0.76 HSP90AA1 (0.46) PYCR1LMNASMN1; SMN2ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1551834-B1 SUBSTITUTED QUINAZOLINONE COMPOUNDS NOVARTIS VACCINES & DIAGNOSTIC (US) 2010-08-25 EP claimed
EP-1502292-A4 POLYMERIC ANTIREFLECTIVE COATINGS DEPOSITED BY PLASMA ENHANCED CHEMICAL VAPOR DEPOSITION BREWER SCIENCE INC (US) 2009-01-21 EP claimed
JP-2005524240-A 2005-08-11 JP claimed
US-6852474-B2 Polymeric antireflective coatings deposited by plasma enhanced chemical vapor deposition BREWER SCIENCE INC. (US) 2005-02-08 US claimed
EP-1502292-A1 POLYMERIC ANTIREFLECTIVE COATINGS DEPOSITED BY PLASMA ENHANCED CHEMICAL VAPOR DEPOSITION Brewer Science, Inc. (US) 2005-02-02 EP claimed
US-20030224586-A1 Polymeric antireflective coatings deposited by plasma enhanced chemical vapor deposition BREWER SCIENCE, INC. 2003-12-04 US claimed
WO-2003094213-A1 POLYMERIC ANTIREFLECTIVE COATINGS DEPOSITED BY PLASMA ENHANCED CHEMICAL VAPOR DEPOSITION BREWER SCIENCE, INC. (US) 2003-11-13 WO claimed
US-20240158390-A1 OTHER HETEROAROMATIC COMPOUNDS HAVING ACTIVITY AGAINST RSV JANSSEN SCIENCES IRELAND UNLMITED COMPANY (IE) 2024-05-16 US disclosed
EP-3784667-B1 HETEROAROMATIC COMPOUNDS HAVING ACTIVITY AGAINST RSV JANSSEN SCIENCES IRELAND UNLIMITED CO (IE) 2023-08-16 EP disclosed
US-11708369-B2 Heteroaromatic compounds having activity against RSV Janssen Sciences Ireland Unlimited Company (IE) 2023-07-25 US disclosed
US-11708369-B2 Heteroaromatic compounds having activity against RSV Janssen Sciences Ireland Unlimited Company (IE) 2023-07-25 US disclosed
EP-3972964-A1 OTHER HETEROAROMATIC COMPOUNDS HAVING ACTIVITY AGAINST RSV Janssen Sciences Ireland Unlimited Company (IE) 2022-03-30 EP disclosed
CN-113874380-A Other heteroaromatic compounds with anti-RSV activity 爱尔兰詹森科学公司 2021-12-31 CN disclosed
EP-1502292-A4 POLYMERIC ANTIREFLECTIVE COATINGS DEPOSITED BY PLASMA ENHANCED CHEMICAL VAPOR DEPOSITION BREWER SCIENCE INC (US) 2009-01-21 EP disclosed
US-20070134733-A1 Raman signature probes and their use in the detection and imaging of molecular processes and structures PARALLAX BIOSYSTEMS, INC. 2007-06-14 US disclosed
US-20070134733-A1 Raman signature probes and their use in the detection and imaging of molecular processes and structures PARALLAX BIOSYSTEMS, INC. 2007-06-14 US disclosed
US-6852474-B2 Polymeric antireflective coatings deposited by plasma enhanced chemical vapor deposition BREWER SCIENCE INC. (US) 2005-02-08 US disclosed
EP-1502292-A1 POLYMERIC ANTIREFLECTIVE COATINGS DEPOSITED BY PLASMA ENHANCED CHEMICAL VAPOR DEPOSITION Brewer Science, Inc. (US) 2005-02-02 EP disclosed
US-20030224586-A1 Polymeric antireflective coatings deposited by plasma enhanced chemical vapor deposition BREWER SCIENCE, INC. 2003-12-04 US disclosed
WO-2003094213-A1 POLYMERIC ANTIREFLECTIVE COATINGS DEPOSITED BY PLASMA ENHANCED CHEMICAL VAPOR DEPOSITION BREWER SCIENCE, INC. (US) 2003-11-13 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240158390-A1 OTHER HETEROAROMATIC COMPOUNDS HAVING ACTIVITY AGAINST RSV MAVS, ZC3HAV1, RNASEH1 PYCR1 119/4885DGAT1 3908/4885KDM1A 3249/4885
US-11708369-B2 Heteroaromatic compounds having activity against RSV MAVS, ZC3HAV1, SARS1 PYCR1 261/4885DGAT1 3731/4885KDM1A 3236/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.